Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Neuisys is a medical technology company specializing in the development and manufacturing of high-end molecular imaging systems, including digital PET/CT and PET/MRI scanners. The company leverages proprietary digital signal processing and high-sensitivity detector technology to provide superior image resolution and diagnostic accuracy for oncology, neurology, and cardiology. Neuisys focuses on integrating advanced hardware with sophisticated reconstruction algorithms to optimize clinical workflows and reduce radiation exposure for patients. Headquartered in Beijing with operations in Taiwan, the company serves a global market of hospitals and research institutions. Their products are designed to support both routine clinical diagnostics and complex medical research applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Neuisys Imaging System Solutions.